The timing of surgery influences mortality and morbidity in adults with severe complicated infective endocarditis: a propensity analysis

Eur Heart J. 2011 Aug;32(16):2027-33. doi: 10.1093/eurheartj/ehp089. Epub 2009 Mar 26.

Abstract

Aims: To determine whether the timing of surgery could influence mortality and morbidity in adults with complicated infective endocarditis (IE).

Methods and results: In 291 consecutive adults with definite IE who underwent surgery during the active phase, we compared those operated on within the first week of antimicrobial therapy (n=95) to those operated on later (n=191). The impact of the timing of surgery on 6-month mortality, relapses, and postoperative valvular dysfunctions (PVD) was analysed using propensity score (PS) analyses. After stratification of the cohort into quintiles based on the PS, ≤1st week surgery was associated with a trend of decrease in 6-month mortality in the quintile of patients with the most likelihood of undergoing this early surgical management [quintile 5: 11% vs. 33%, odds ratio (OR)=0.18, 95% CI (confidence interval) 0.04-0.83, P=0.03]. Patients of this subgroup were younger, were more likely to have Staphylococcus aureus infections, congestive heart failure, and larger vegetations. Besides, ≤1st week surgery was associated with an increased number of relapses or PVD (16% vs. 4%, adjusted OR=2.9, 95% CI 0.99-8.40, P=0.05).

Conclusion: Surgery performed very early may improve survival in patients with the most severe complicated IE. However, a greater risk of relapses and PVD should be expected when surgery is performed very early.

MeSH terms

  • Abscess / complications
  • Abscess / mortality
  • Aged
  • Anti-Bacterial Agents / therapeutic use
  • Embolism / complications
  • Embolism / mortality
  • Endocarditis, Bacterial / complications
  • Endocarditis, Bacterial / mortality*
  • Endocarditis, Bacterial / surgery*
  • Female
  • Heart Failure / complications
  • Heart Failure / mortality
  • Heart Valve Prosthesis Implantation / mortality
  • Humans
  • Male
  • Middle Aged
  • Propensity Score
  • Prospective Studies
  • Recurrence
  • Shock, Cardiogenic / complications
  • Shock, Cardiogenic / mortality
  • Staphylococcal Infections / complications
  • Staphylococcal Infections / mortality*
  • Staphylococcal Infections / surgery*
  • Time Factors
  • Treatment Outcome

Substances

  • Anti-Bacterial Agents